Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Aguora Hills, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Oncotelic Therapeutics, Inc. has filed 1,215 SEC EDGAR filings since 04 Apr 1996

SEC filing history

Showing 551-575 of 781 matching filings.

Per page
25
Current page
23
SC 13G File 005-45691

SABBY 13G OXBT 04.18.13

Filing date
18 Apr 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

FORM 8-K

Filing date
11 Apr 2013
Reporting date
10 Apr 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

FORM 8-K

Filing date
09 Apr 2013
Reporting date
09 Apr 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

FORM 8-K FILING DOCUMENT

Filing date
12 Mar 2013
Reporting date
12 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

FORM 8-K

Filing date
06 Mar 2013
Reporting date
05 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
28 Feb 2013
Reporting date
27 Feb 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
28 Feb 2013
Reporting date
27 Feb 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

FORM 8-K

Filing date
28 Feb 2013
Reporting date
27 Feb 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

FORM 8-K

Filing date
22 Feb 2013
Reporting date
22 Feb 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-181813

424B5

Filing date
22 Feb 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

FORM 8-K FILING DOCUMENT

Filing date
06 Feb 2013
Reporting date
06 Feb 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

CHAPLIN - FORM 4

Filing date
24 Jan 2013
Reporting date
23 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
3

CHAPLIN - FORM 3

Filing date
24 Jan 2013
Reporting date
23 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

FORM 8-K

Filing date
23 Jan 2013
Reporting date
23 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

FORM 8-K

Filing date
16 Jan 2013
Reporting date
14 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

FORM 8-K

Filing date
15 Jan 2013
Reporting date
15 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

TAMAR HOWSON JANUARY 2013 STOCK AND OPTION GRANT

Filing date
03 Jan 2013
Reporting date
02 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

DR. GERALD MCMAHON JANUARY 2013 OPTION GRANT

Filing date
03 Jan 2013
Reporting date
02 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

WILLIAM SCHWIETERMAN JANUARY 2013 STOCK GRANT

Filing date
03 Jan 2013
Reporting date
02 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

ALASTAIR WOOD JANUARY 2013 STOCK GRANT

Filing date
03 Jan 2013
Reporting date
02 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

FORM 8-K

Filing date
27 Dec 2012
Reporting date
21 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

FORM 8-K FILING DOCUMENT

Filing date
10 Dec 2012
Reporting date
10 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-178692

OXIGENE, INC. 424B3

Filing date
27 Nov 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

FORM 8-K FILING DOCUMENT

Filing date
21 Nov 2012
Reporting date
21 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .